日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

Global EditionASIA 中文雙語Fran?ais
Opinion
Home / Opinion / Opinion Line

Tariff cuts on imported drugs show pricing system needs reforming

China Daily | Updated: 2018-06-12 07:22
Share
Share - WeChat

CHINA EXEMPTED TARIFFS on 28 categories of imported medicines, including some common anti-cancer drugs, on May 1. But the retail prices of these medicines have remained unchanged till now. Beijing News comments:

It is disappointing that the zero-tariff policy that has been implemented for nearly one and a half months has not yet brought any tangible benefits to patients.

After China cut tariffs on imported cars last month, the retail prices of some imported vehicles came down almost simultaneously. So people have enough reasons to ask why the retail prices of imported medicines have not yet changed.

It is because the imported vehicles' prices are mainly decided by the market, but medicine prices are fixed by the government according to relevant laws and regulations.

Also the prices of medicines are not decided by one department, but based on the negotiations of different departments, such as the National Health Commission, the National Development and Reform Commission, the Ministry of Civil Affairs, as well as the government's bargaining with the pharmaceutical companies, or else determined by purchase bidding.

The complicated procedure means it usually takes several months to adjust the prices of medicines.

Also imported medicines are sold by agents or branches of foreign pharmaceutical companies in China according to the price approved by the authorities. So the adjustment of a medicine's retail price entails negotiations among all the relevant parties.

Some multinational pharmaceutical companies have a strong say in pricing, particularly in the fields they dominate, while, in contrast, the vehicle market is more competitive. Therefore, it is unrealistic to expect a swift reduction in the retail price of medicine after the tax adjustment.

China should reform its medicine pricing policies and streamline the pricing mechanism. And in the negotiations with foreign pharmaceutical companies, we can learn from the practice of other countries and make use of policy options such as compulsory licensing and parallel importation.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 在线高清免费观看 | 欧美一区二区在线免费观看 | 日本黄色片网址 | 亚洲黄色成人网 | 99久久精品国产成人一区二区 | 欧美毛片视频 | 日韩精品亚洲一区 | 深夜福利在线播放 | 日韩视频网址 | 成人激情av | 蜜臀av一区二区 | 日韩精品在线免费视频 | 青青免费在线视频 | 日本黄色免费 | 97精品国产97久久久久久粉红 | 久精品视频| 91在线免费视频 | 成人激情视频网站 | 日韩欧美影院 | 福利视频一区二区三区 | 毛片在线网址 | 蜜桃在线一区 | 成人资源在线观看 | 欧美激情xxxxx | 麻豆视频在线观看免费网站黄 | 69夜色精品国产69乱 | 成年人精品 | 国产无精乱码一区二区三区 | 久久国产片| 精品一二三区 | 欧美成人一区二区三区片免费 | 亚洲综合在线视频 | 国产性精品 | 免费黄色av网址 | 国产精品久久久久影院老司 | 国产精品免费看 | 国产精品久久久久永久免费看 | 91在线视频免费看 | 午夜一级| 国产喷水在线观看 | 亚洲熟区|